NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Institute of Medicine (US) Forum on Medical and Public Health Preparedness for Catastrophic Events. The 2009 H1N1 Influenza Vaccination Campaign: Summary of a Workshop Series. Washington (DC): National Academies Press (US); 2010.

Cover of The 2009 H1N1 Influenza Vaccination Campaign

The 2009 H1N1 Influenza Vaccination Campaign: Summary of a Workshop Series.

Show details

BWorkshop Agendas1

Raleigh Workshop

April 15, 2010

Renaissance Raleigh North Hills Hotel

Raleigh, North Carolina

Austin Workshop

April 27, 2010

AT&T Executive Education and Conference Center

Austin, Texas

Seattle Workshop

May 11, 2010

The Alexis Hotel Seattle

Seattle, Washington

Workshop Objectives

Following the recent, and ongoing, H1N1 vaccination campaigns, the objectives of this workshop are to

  • Examine innovative efforts used to distribute and administer vaccine and discuss how they may inform future efforts.
  • Examine how jurisdictions and providers interpreted and applied the CDC/ACIP recommendations for use of H1N1 vaccine.
  • Highlight successful approaches used by jurisdictions to develop and use innovative partnerships with traditional and non-traditional partners, such as community groups and the private sector, to enhance communication with the public and providers and to effectively distribute and administer vaccine.
  • Discuss strategies used to collect, monitor, evaluate, and use data during the H1N1 vaccination campaigns.
  • Discuss lessons learned and challenges that arose during the vaccination campaigns, and identify strategies to address these challenges for future emergency vaccination programs and other medical countermeasures dispensing campaigns.

Welcoming Remarks

Raleigh

  • Jeffrey Engel, North Carolina Department of Health and Human Services

Austin

  • David Lakey, Texas Department of State Health Services

Seattle

  • Mary Selecky, Washington State Department of Health

Charge to Workshop Speakers and Participants

Raleigh, Seattle

  • Jay Butler, Workshop Co-Chair, Centers for Disease Control and Prevention

Austin, Seattle

  • Jeffrey Duchin, Workshop Co-Chair, Public Health–Seattle & King County, WA

SESSION I. DISTRIBUTION STRATEGIES

Session Objectives

  • Provide an overview of strategies developed to receive, store, and distribute vaccine to participating H1N1 vaccine providers and administration sites in the community and strategies developed to administer vaccine:
    • How were providers and vaccinators recruited to participate in the H1N1 vaccination program? What partnerships were used? Did these partnerships rely on preexisting relationships and, if so, were they successful? Were new partnerships built?
    • What lessons were learned from the use of a centralized distribution mechanism?
    • Was vaccine distributed to administration sites through centralized healthcare system distribution sites or directly to administration sites?
    • How did the availability of specific vaccine formulations and indications impact distribution and administration strategies?
  • Discuss the successes, lessons learned, and how challenges might be addressed to help improve future emergency vaccination programs and other medical countermeasure campaigns.

Overview and Panel Objectives

Raleigh, Seattle

  • Jay Butler, Panel Chair, Centers for Disease Control and Prevention

Austin

  • Jeffrey Duchin, Panel Chair, Public Health–Seattle & King County, WA

Panel Remarks

Raleigh

  • Susan Cooper, Tennessee Department of Health
  • Anne Bailowitz, Baltimore City Health Department, MD
  • James Turner, American College Health Association
  • Amanda Fuller, North Carolina Department of Health and Human Services
  • Greg Primuth, Walgreens
  • Kim Boggess, University of North Carolina at Chapel Hill and the American College of Obstetricians and Gynecologists

Austin

  • Don Williamson, Alabama Department of Public Health
  • John Redd, Indian Health Service
  • Ann Salyer-Caldwell, Tarrant County Public Health, TX
  • Jay Bueche, H-E-B
  • Jeanne Sheffield, University of Texas Southwestern Medical Center and the American College of Obstetricians and Gynecologists
  • Wayne Hachey, Office of the Assistant Secretary of Defense (Health Affairs)

Seattle

  • Mark Horton, California Department of Public Health
  • David Fleming, Public Health–Seattle & King County, WA
  • Jennifer Arnold, Washington State Pharmacy Association
  • Neil Kaneshiro, Woodinville Pediatrics, WA, and the Washington State Chapter of the American Academy of Pediatrics
  • J. Michael Muhm, The Boeing Company
  • Leonardo Pereira, Oregon Health and Science University

Discussion with Panelists and Attendees

SESSION II. PROGRAM IMPLEMENTATION AND VACCINE ADMINISTRATION

Session Objectives

  • Examine how jurisdictions and providers interpreted and applied the CDC/ACIP guidance:
    • Was vaccine administered sequentially or simultaneously to groups within the target population?
    • Was vaccine restricted to subgroups within the target population?
    • Was vaccine administered to groups outside the target population? If so, how and why was that decision made?
    • How was demand among target populations assessed?
    • What criteria were used for expanding beyond initial target populations?
    • What challenges arose in the interpretation, implementation, and regional coordination of CDC/ACIP recommendations for H1N1 vaccination? Would a more restrictive, uniform approach have been desirable, or was the flexibility of the CDC/ACIP guidance important?
    • How did local interpretation of CDC/ACIP guidance influence strategy for vaccine administration?
  • Discuss lessons learned and how challenges might be addressed to help improve future emergency vaccination programs and other medical countermeasure campaigns.

Overview and Panel Objectives

Raleigh, Austin

  • David Lakey, Panel Chair, Texas Department of State Health Services

Seattle

  • Jeffrey Duchin, Panel Chair, Public Health–Seattle & King County, WA

Panel Remarks

Raleigh

  • Lauren Smith, Massachusetts Department of Public Health
  • Rahul Gupta, Kanawha–Charleston Health Department, WV
  • Beverly Pritchett, Washington, DC, Department of Health
  • Scott Needle, Collier Health Services, Inc., FL, and the American Academy of Pediatrics
  • Carol Cunningham, Ohio Department of Public Safety
  • John Carson Rounds, Village Family Care, NC, and the American Academy of Family Physicians

Austin

  • Julie Morita, Chicago Department of Public Health, IL
  • Perry Bynum, Haltom City Fire/Rescue, TX
  • Stephen Blair, American Academy of Family Physicians
  • Jason Terk, Cook Children’s Physician Network, TX, and the Texas Pediatrics Society
  • Tom Shimabukuro, Centers for Disease Control and Prevention

Seattle

  • Teresa Garrett, Utah Department of Health
  • Kristen Ehresmann, Minnesota Department of Health
  • Joe Finkbonner, Northwest Portland Area Indian Health Board
  • Alonzo Plough, County of Los Angeles Department of Public Health, CA
  • David Grossman, Group Health Cooperative, WA

Discussion with Panelists and Attendees

SESSION III. COMMUNICATION STRATEGIES

Session Objectives

  • Provide an overview of strategies used by communities to inform the general public, vulnerable populations, select target populations, and priority workforce (e.g., healthcare providers and first responders) about the threat of the pandemic and the availability of and eligibility for vaccine:
    • What strategies were successful and unsuccessful in developing and delivering communication messages for specific segments of the population?
    • What particular challenges were associated with different population groups?
    • Given the challenges of vaccine availability, what strategies were used to manage expectations of providers, target populations, and the public?
    • How were target populations informed about vaccine availability?
    • How were target populations assured about vaccine safety?
  • Discuss lessons learned and how challenges might be addressed to help improve future emergency vaccination programs and other medical countermeasure campaigns.

Overview and Panel Objectives

Raleigh, Seattle

  • Jack Herrmann, Panel Chair, National Association of County and City Health Officials

Austin

  • Kristine Sheedy, Panel Chair, Centers for Disease Control and Prevention

Panel Remarks

Raleigh

  • Karyl Rattay, Delaware Department of Health and Social Services
  • Pamela Blackwell, Cobb & Douglas Public Health, GA
  • David Brown, The Washington Post
  • Benjamin Rackley, Tuskegee Area Health Education Center, Inc., AL
  • Julie Henry, North Carolina Department of Health and Human Services

Austin

  • Paul Halverson, Arkansas Department of Health
  • Leslea Bennett-Webb, Oklahoma State Department of Health
  • Candace Crause, Champaign-Urbana Public Health District, IL
  • Greg Bogdan, Rocky Mountain Poison & Drug Center at Denver Health, CO
  • Maggie Fox, Reuters

Seattle

  • Selena Manychildren, Navajo Division of Health
  • Mohamed Sheikh Hassan, Afrique Service Center, WA
  • Tiffany Sutter, California Department of Public Health
  • Greg Wilkinson, State of Alaska Health and Social Services

Discussion with Panelists and Attendees

SESSION IV. MONITORING, IMPACT, AND EVALUATION

Session Objectives

  • Examine and discuss strategies that were used to collect, monitor, evaluate, and use data during the H1N1 vaccination campaign:
    • What data were used to ascertain the impact and reach of this immunization effort?
    • What data would have been especially helpful but were not available?
    • How can data be gathered and analyzed quickly during an event in order to drive policy immediately?
    • Was it possible to assess vaccine coverage? What levels of coverage were achieved among different populations, and did the H1N1 vaccination campaign adequately immunize persons in the ACIP target groups?
    • What data were used or would be most useful to improve immunization rates for persons in the target groups and in the general population?
  • Discuss lessons learned and how monitoring, impact, and evaluation can be improved for future emergency vaccination programs and other medical countermeasure campaigns.

Overview and Panel Objectives

Raleigh

  • Cathy Slemp, Panel Chair, West Virginia Department of Health and Human Resources

Austin

  • B. Tilman Jolly, Panel Chair, Department of Homeland Security

Seattle

  • Beth Bell, Panel Chair, Centers for Disease Control and Prevention

Panel Remarks

Raleigh

  • Karen Remley, Virginia Department of Health
  • David Gruber, New Jersey Department of Health and Senior Services
  • Beth Maldin Morgenthau, New York City Department of Health and Mental Hygiene, NY
  • Laura Williams, Boston EMS, MA
  • Pascale Wortley, Centers for Disease Control and Prevention
  • Beth Rowe-West, Association of Immunization Managers

Austin

  • Daniel Hopfensperger, Wisconsin Department of Health Services
  • Eduardo Sanchez, Blue Cross and Blue Shield of Texas
  • Angie Hagy, City of Milwaukee Health Department, WI
  • Pamela Falk, University of Texas Medical Branch at Galveston

Seattle

  • Cathy Slemp, West Virginia Department of Health and Human Resources
  • Anthony L.-T. Chen, Tacoma–Pierce County Health Department, WA
  • Laurene Mascola, Los Angeles County Department of Public Health, CA
  • Richard Justman, UnitedHealth Group

Discussion with Panelists and Attendees

SESSION V. GENERAL DISCUSSION WITH WORKSHOP PARTICIPANTS AND ATTENDEES

Session Objectives

Discuss opportunities and constraints identified during the workshop that may help inform future efforts to administer vaccine and dispense medical countermeasures. As future campaigns are developed and time-dependent scenarios considered, what improvements are needed to ensure a safe, robust, and timely response?

Panel Discussion: Implementing the Lessons Learned

Raleigh

  • Lisa Koonin, Panel Chair, Centers for Disease Control and Prevention
  • Cathy Slemp, West Virginia Department of Health and Human Resources
  • Pamela Blackwell, Cobb & Douglas Public Health, GA
  • Scott Needle, Collier Health Services Inc., FL, and the American Academy of Pediatrics

Austin

  • Jeffrey Duchin, Panel Co-Chair, Public Health–Seattle & King County, WA
  • Lisa Koonin, Panel Co-Chair, Centers for Disease Control and Prevention
  • Toby Merlin, Centers for Disease Control and Prevention
  • David Lakey, Texas Department of State Health Services

Seattle

  • Toby Merlin, Panel Chair, Centers for Disease Control and Prevention
  • James Blumenstock, Association of State and Territorial Health Officials
  • Cathy Slemp, West Virginia Department of Health and Human Resources
  • Jack Herrmann, National Association of County and City Health Officials

Moderated Discussion with Panelists and Attendees

  • What new ideas have surfaced in this meeting today that should be explored further?
  • Were lessons learned during the pandemic response that could enhance efforts to reduce the burden of seasonal flu in future years?
  • Were any examples discussed that could be implemented immediately to improve the efficiency and effectiveness of the vaccine administration system?
  • What further evaluation questions remain?

Closing Remarks

Raleigh

  • Jay Butler, Workshop Co-Chair, Centers for Disease Control and Prevention

Austin, Seattle

  • Jeffrey Duchin, Workshop Co-Chair, Public Health–Seattle & King County, WA

To save space, the individual agendas from each regional meeting have been compiled into a single document. Under each session, speakers have been identified based on the meeting location where they participated: Raleigh, Austin, and/or Seattle.

Footnotes

1

To save space, the individual agendas from each regional meeting have been compiled into a single document. Under each session, speakers have been identified based on the meeting location where they participated: Raleigh, Austin, and/or Seattle.

Copyright © 2010, National Academy of Sciences.
Bookshelf ID: NBK54184
PubReader format: click here to try

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (715K)

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...